Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the last decade, the volume of clinical trial data has surged, presenting unprecedented ...

Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study Each round of manual data review, cleaning, and reconciliation ...

Navigating today’s rapidly evolving clinical trial landscape can be tough. With intricate protocols and shifting regulatory demands, it’s more difficult than ever to find and keep participants, as ...

Physicians, struggling under the pressure of heavy patient loads amidst a national clinical workforce shortage, continue to rank working with EHR systems as the second most challenging part of the job ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

For decades, hospitals and health systems have invested heavily in brand advertising. Gleaming facilities, award logos, ...

IRVING, Texas--(BUSINESS WIRE)--Vizient ® announces the Top Performers in clinical quality and sustainability excellence, recognizing hospitals and healthcare organizations nationwide for their ...

This study examines the impact of geographically limited disasters on health care quality performance scores of Medicare Advantage contracts, finding limited impact on performance scores. Objective: ...

For the tenth year, CMS named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based ...